These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19863350)

  • 1. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
    Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
    Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
    Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
    Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
    Garner EI; Stokes EE; Berkowitz RS; Mok SC; Cramer DW
    Cancer Res; 2002 Jun; 62(11):3058-62. PubMed ID: 12036914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
    Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
    Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y; Li DK; Wu J; Zhang Z; Gao E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
    Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
    Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
    Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
    Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
    Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females.
    Yin PH; Lee HC; Chau GY; Liu TY; Liu HC; Lui WY; Chi CW
    Cancer Lett; 2004 Aug; 212(2):195-201. PubMed ID: 15341023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
    Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
    Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
    Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of polymorphism and expression of oestrogen metabolism-related genes in Chinese women with premature ovarian insufficiency.
    Qin C; Chen Y; Lin Q; Yao J; Wu W; Xie J
    Reprod Biomed Online; 2017 Nov; 35(5):609-615. PubMed ID: 28887105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in estrogen-metabolizing genes and their association with genomic instability in untreated breast cancer patients and healthy women.
    dos Santos RA; Teixeira AC; Mayorano MB; Carrara HH; de Andrade J; Takahashi CS
    J Biomed Biotechnol; 2011; 2011():571784. PubMed ID: 21716904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
    Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
    Miyoshi Y; Noguchi S
    Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.